Can fish oil help guard against schizophrenia?

	Tweet

Taking fish oil may help prevent full-blown psychotic illness in at-risk adolescents and young adults, a study released today hints.

These at-risk individuals may have weak or transient psychotic symptoms, and already show schizophrenia-like brain changes, Dr. G. Paul Amminger of The University of Melbourne in Australia, a researcher on the study, told Reuters Health. But while psychiatrists now know how to identify these individuals, he added, they don’t know what to do with them. “At the moment there’s no state-of-the-art guideline (on) how to treat those people.”

Prescribing antipsychotic medications may be helpful, Amminger added, but these medications have serious side effects, and can also be stigmatizing. “For young people they don’t want to commit themselves to a treatment which they might need to take for the next five to ten years,” he said. Furthermore, only about a third of people at high risk for psychotic disorders will go on to develop full-fledged mental illness in a given year.

There’s considerable evidence that abnormal fatty acid metabolism may contribute to the development of schizophrenia, Amminger and his team note in the Archives of General Psychiatry. To investigate whether omega-3 fatty acids might help prevent psychotic illness, they randomly assigned 81 at-risk individuals, 13 to 25 years old, to take 1.2 grams a day of omega-3s in fish oil capsule form or a placebo for 12 weeks and then followed them for another 40 weeks.

The researchers included people who met at least one of the following three criteria: having low-level psychotic symptoms; having transient psychotic symptoms; or having a schizophrenia-like personality disorder or a close relative with schizophrenia, along with a sharp decline in mental function within the past year.

Seventy-six of the 81 study participants, or 94 percent, completed the trial, Amminger noted, which underscores the safety and tolerability of fish oil.

At one year, 5 percent of the study participants taking omega-3s had developed a psychotic disorder (2 of 41 people), compared to 28 percent of those on placebo (11 of 40). People taking fish oil also showed significant reductions in their psychotic symptoms and improvements in function, while they were at no greater risk of adverse effects than people taking placebo capsules.

The effect of fish oil capsules, Amminger noted, was similar to that seen in two trials of antipsychotic drugs in at-risk individuals.

There are a number of mechanisms through which omega-3s could protect the brain, Amminger said; they are a major component of brain cells. They are also key to the proper function of two brain chemical signaling systems, dopamine and serotonin, which have been implicated in schizophrenia. Fish oil also boosts levels of glutathione, an antioxidant that protects the brain against oxidative stress.

Trials of medications for treating mental illness typically don’t include people younger than 18, Amminger noted, while starting minors on these medications is “always very difficult, and always quite controversial.”

But if future research bears out the current findings, he added, fish oil promises to offer a safe way to help prevent psychosis in at-risk people, and could also potentially be used to prevent or delay the onset of chronic depression, bipolar illness, and substance abuse disorder—all of which are far more common than psychotic illness.

He and his colleagues are now planning a multicenter trial of fish oil for the prevention of psychotic illness in 320 at-risk people.

SOURCE: Archives of General Psychiatry, February 2010.

RELATED STORIES:
Discovery of new gene mutation in schizophrenia offers a new target for drug therapies   Genetic mutations may be responsible for schizophrenia   Glutamate: Too much of a good thing in schizophrenia?   Schizophrenia-type illness linked to heart risk   Mutations not inherited from parents cause more than half the cases of schizophrenia   Parasite may trigger schizophrenia   Alterations in Brain’s White Matter Key to Schizophrenia   Altered Brain Activity in Schizophrenia May Direct Focus on Self   Theory of mind in schizophrenia   Drug abuse underlies schizophrenia tie to violence   Cancer risk varies in patients with schizophrenia   Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: study   Mental illness: Probing the causes of schizophrenia, depression and anxiety   Depression and schizophrenia ‘should be treated with therapy’   Why Schizophrenia Affect Men More Than Women

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]